Re: AGM 2018 - Masila Notes
in response to
by
posted on
Jun 12, 2019 09:07PM
This is I think where I got the idea that patients might have the option to continue taking Apabetalone after the trial wrapped up....from masila's notes from Sept's AGM, the post to which I am replying....here's the relevant section that probably led me to think this:
Apparently all patients interviewed want to stay on the treatment. Some have been on close to 36 months. That speaks volumes to me!